| Emily Davies, DO | |
|
1800 W Charleston Blvd, Las Vegas, NV 89102-2329 | |
| (702) 383-2000 | |
| Not Available |
| Full Name | Emily Davies |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 1800 W Charleston Blvd, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396139358 | NPI | - | NPPES |
| Entity Name | Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
Sosei Group Corporation confirms the information released today by Novartis that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Seebri (glycopyrronium bromide) Inhalation Capsules 50 mcg administered through the Breezhaler device, as a once-daily, long-term, inhaled maintenance bronchodilator treatment for the relief of various symptoms due to airway obstructive disease in chronic obstructive pulmonary disease.
Both simple and advanced computed tomography were effective in accurately predicting which stroke patients would benefit from endovascular thrombectomy to remove a large cerebral clot, but together they were even better, reported researchers at The University of Texas Health Science Center at Houston.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
Prostate cancer is the most common form of cancer in men. Affecting about 1 in 6 men, it is the second deadliest cancer. Research has been stymied by imperfect animal models of the disease, which are costly, take considerable time to develop, and fail to mimic the most lethal aspects of the illness.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Davies, DO Po Box 744785, Atlanta, GA 30374-4785 Ph: (202) 476-5000 | Emily Davies, DO 1800 W Charleston Blvd, Las Vegas, NV 89102-2329 Ph: (702) 383-2000 |
News Archive
Sosei Group Corporation confirms the information released today by Novartis that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Seebri (glycopyrronium bromide) Inhalation Capsules 50 mcg administered through the Breezhaler device, as a once-daily, long-term, inhaled maintenance bronchodilator treatment for the relief of various symptoms due to airway obstructive disease in chronic obstructive pulmonary disease.
Both simple and advanced computed tomography were effective in accurately predicting which stroke patients would benefit from endovascular thrombectomy to remove a large cerebral clot, but together they were even better, reported researchers at The University of Texas Health Science Center at Houston.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
Prostate cancer is the most common form of cancer in men. Affecting about 1 in 6 men, it is the second deadliest cancer. Research has been stymied by imperfect animal models of the disease, which are costly, take considerable time to develop, and fail to mimic the most lethal aspects of the illness.
SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.
› Verified 8 days ago
Randi E Lampert, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2050 Mariner Dr, Suite #150, Las Vegas, NV 89128 Phone: 702-228-9066 | |
Sora Song, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3201 S Maryland Pkwy Ste 608, Las Vegas, NV 89109 Phone: 702-457-5437 Fax: 702-464-5801 | |
Dr. Noah Benjamin Kohn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1800 W. Charleston Blvd., Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 888-456-2467 | |
David Blank, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10105 Banburry Cross Dr, Suite 370, Las Vegas, NV 89144 Phone: 702-260-4525 Fax: 702-869-0133 | |
Vicki Hom, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4570 S. Eastern Ave, Suite #21, Las Vegas, NV 89119 Phone: 702-733-6033 Fax: 702-733-6033 | |
Ms. Elsa H Von Schulenburg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4800 Alpine Pl, Suite 10, Las Vegas, NV 89107 Phone: 702-851-3572 Fax: 702-851-3574 | |
Ruben J Acherman, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3131 La Canada St Ste 230, Las Vegas, NV 89169 Phone: 702-732-1290 Fax: 702-732-1385 |